Literature DB >> 12549789

Predictive values of serial C-reactive protein in neonatal sepsis.

Pracha Nuntnarumit1, Orawan Pinkaew, Sureewan Kitiwanwanich.   

Abstract

BACKGROUND: Infection is one of the major problems in neonates. The diagnosis of neonatal septicemia is difficult to establish based on the clinical criteria alone. However, empirical treatment should not be delayed because of the high mortality. Laboratory tests used to support diagnosis have shown variable predictive values. C-reactive protein (CRP), an acute phase protein, increases in inflammatory disorders and tissue injury. Serial CRP have been shown to be more useful than a single measured CRP in the diagnostic evaluation of neonates with suspected infection.
OBJECTIVES: 1. To evaluate the diagnostic accuracy of serial CRP in neonatal sepsis. 2. To compare the diagnostic values between CRP and leukocyte index from a complete blood count (CBC).
METHOD: A prospective observational study included newborn infants, aged > 3 days and diagnosed with clinical sepsis, who were admitted in the newborn intensive care unit and special care nursery at Ramathibodi Hospital during a 14-months period. Newborn infants who received antibiotics prior to septic work up were excluded. CRP levels were measured initially at the time of septic work-up and at 24-48 hours later. Investigations for infection included CBC, blood culture and urine culture. Radiological study and lumbar puncture were performed if clinically indicated. Based on clinical and biological data, diagnosis of infants can be categorized into 4 groups as follows; (1) proven sepsis with positive culture, (2) localized infection with negative culture, (3) probable infection (clinically consistent with sepsis, negative culture without localized infection), and (4) no infection (findings not consistent with sepsis and antibiotics were discontinued within 3 days). Diagnosis was made before the CRP results were known.
RESULTS: Of 76 newborn infants with 90 episodes of clinical sepsis, there were 24 episodes of proven sepsis, 11 episodes of localized infection with negative culture, 18 episodes of probable infection and 37 episodes of no infection. Serial CRP had better predictive values than those of CBC. The sensitivity, specificity, positive predictive value, and negative predictive value of CRP for proven sepsis and localized infection at cutoff point > or = 5 mg/L were 100 per cent, 94 per cent, 91.6 per cent and 100 per cent respectively. False positive CRP were found in post-operative patent ductus arteriosus ligation, intracerebral hemorrhage, and post resuscitation with chest compression. To improve the predictive value of CBC, analysis of the receiver operating characteristic (ROC) curve showed that the predictive value of CBC for sepsis would be enhanced by using abnormal leukocyte index 2 2 parameters.
CONCLUSIONS: Predictive value of CRP could be enhanced by serial rather than a single measurement. Serial CRP showed very high predictive values for diagnosis of neonatal sepsis and were better than those of leukocyte indices of CBC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12549789

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  12 in total

1.  Antibiotic stewardship in NICU: De-implementing routine CRP to reduce antibiotic usage in neonates at risk for early-onset sepsis.

Authors:  Neetu Singh; James E Gray
Journal:  J Perinatol       Date:  2021-06-08       Impact factor: 2.521

2.  Different antibiotic strategies in transient tachypnea of the newborn: an ambispective cohort study.

Authors:  Jinhui Li; Jinlin Wu; Lizhong Du; Yong Hu; Xiaoyan Yang; Dezhi Mu; Bin Xia
Journal:  Eur J Pediatr       Date:  2015-04-02       Impact factor: 3.183

3.  Sensitivity pattern among bacterial isolates in neonatal septicaemia in port Harcourt.

Authors:  Boma A West; Oliemen Peterside
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-03-26       Impact factor: 3.944

4.  Management of neonatal sepsis at Muhimbili National Hospital in Dar es Salaam: diagnostic accuracy of C-reactive protein and newborn scale of sepsis and antimicrobial resistance pattern of etiological bacteria.

Authors:  Martha Franklin Mkony; Mucho Michael Mizinduko; Augustine Massawe; Mecky Matee
Journal:  BMC Pediatr       Date:  2014-12-05       Impact factor: 2.125

5.  Validation of serum C-reactive protein for the diagnosis and monitoring of antibiotic therapy in neonatal sepsis.

Authors:  Ejaz Ahmed; Abdur Rehman; Muhammad Asghar Ali
Journal:  Pak J Med Sci       Date:  2017 Nov-Dec       Impact factor: 1.088

6.  Clinical symptoms, laboratory, and microbial patterns of suspected neonatal sepsis cases in a children's referral hospital in northwestern Iran.

Authors:  Majid Mahallei; Mohammad Ahangarzadeh Rezaee; Bahareh Mehramuz; Shayan Beheshtirooy; Babak Abdinia
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

7.  Prospective evaluation of the usefulness of C-reactive protein in the diagnosis of neonatal sepsis in a sub-Saharan African region.

Authors:  Boma A West; Oliemen Peterside; Rosemary O Ugwu; Augusta U Eneh
Journal:  Antimicrob Resist Infect Control       Date:  2012-06-01       Impact factor: 4.887

8.  C-reactive protein for diagnosing late-onset infection in newborn infants.

Authors:  Jennifer Valeska Elli Brown; Nicholas Meader; Jemma Cleminson; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2019-01-14

9.  Serum amyloid A, procalcitonin, tumor necrosis factor-alpha, and interleukin-1beta levels in neonatal late-onset sepsis.

Authors:  Birsen Ucar; Bilal Yildiz; M Arif Aksit; Coskun Yarar; Omer Colak; Yildiz Akbay; Ertugrul Colak
Journal:  Mediators Inflamm       Date:  2008-11-16       Impact factor: 4.711

10.  Utility of qualitative C- reactive protein assay and white blood cells counts in the diagnosis of neonatal septicaemia at Bugando Medical Centre, Tanzania.

Authors:  Flora Chacha; Mariam M Mirambo; Martha F Mushi; Neema Kayange; Antke Zuechner; Benson R Kidenya; Stephen E Mshana
Journal:  BMC Pediatr       Date:  2014-10-03       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.